INJECTION SITE CALCIFICATION

INJECTION SITE CALCIFICATION was reported 125 times

These drug classes are most commonly taken by patients reporting INJECTION SITE CALCIFICATION:

# Drug Count
0 Interferon beta [EPC] 30
1 Corticosteroid [EPC] 11
2 GLP-1 Receptor Agonist [EPC] 6
3 Insulin Analog [EPC] 6
4 Tissue-nonspecific Alkaline Phosphatase [EPC] 6
5 Benzodiazepine [EPC] 5
6 Anti-IgE [EPC] 3
7 Insulin [EPC] 3
8 Nonsteroidal Anti-inflammatory Drug [EPC] 3
9 Potassium Channel Blocker [EPC] 3
10 Provitamin D2 Compound [EPC] 3
11 Vascular Endothelial Growth Factor Inhibitor [EPC] 3
12 Vitamin C [EPC] 3
13 Angiotensin 2 Receptor Blocker [EPC] 2
14 Atypical Antipsychotic [EPC] 2
15 Expectorant [EPC] 2
16 Folate Analog Metabolic Inhibitor [EPC] 2
17 HMG-CoA Reductase Inhibitor [EPC] 2
18 Osmotic Laxative [EPC] 2
19 Parathyroid Hormone Analog [EPC] 2
20 Tumor Necrosis Factor Blocker [EPC] 2
21 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2
22 Acetylcholine Release Inhibitor [EPC] 1
23 Angiotensin Converting Enzyme Inhibitor [EPC] 1
24 Arteriolar Vasodilator [EPC] 1
25 Azole Antifungal [EPC] 1
26 Calcitonin [EPC] 1
27 Calcium Channel Blocker [EPC] 1
28 Calcium [EPC] 1
29 Cardiac Glycoside [EPC] 1
30 Dihydropyridine Calcium Channel Blocker [EPC] 1
31 Ergot Derivative [EPC] 1
32 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
33 Histamine-1 Receptor Antagonist [EPC] 1
34 Interleukin-17A Antagonist [EPC] 1
35 Interleukin-4 Receptor alpha Antagonist [EPC] 1
36 Loop Diuretic [EPC] 1
37 Neuromuscular Blocker [EPC] 1
38 Nicotinic Acid [EPC] 1
39 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
40 Phenylalanine Metabolizing Enzyme [EPC] 1
41 Polyene Antifungal [EPC] 1
42 Prostaglandin Analog [EPC] 1
43 RANK Ligand Inhibitor [EPC] 1
44 Selective T Cell Costimulation Modulator [EPC] 1
45 Sympathomimetic-like Agent [EPC] 1
46 Thiazide Diuretic [EPC] 1
47 Topoisomerase Inhibitor [EPC] 1
48 Xanthine Oxidase Inhibitor [EPC] 1